↓ Skip to main content

Why Single-Cell Sequencing Has Promise in MDS

Overview of attention for article published in Frontiers in oncology, December 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
1 X user

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Why Single-Cell Sequencing Has Promise in MDS
Published in
Frontiers in oncology, December 2021
DOI 10.3389/fonc.2021.769753
Pubmed ID
Authors

Xuan Zhang, H. Leighton Grimes

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 25%
Student > Master 4 20%
Professor 1 5%
Unspecified 1 5%
Unknown 9 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 30%
Medicine and Dentistry 3 15%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unspecified 1 5%
Unknown 9 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2021.
All research outputs
#17,492,431
of 25,658,541 outputs
Outputs from Frontiers in oncology
#8,136
of 22,758 outputs
Outputs of similar age
#306,122
of 516,143 outputs
Outputs of similar age from Frontiers in oncology
#465
of 1,364 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,143 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,364 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.